| Dr Raymond Justin Myles Jr, PSYD | |
|
609a Warrior Road, Fort Riley, KS 66442 | |
| (785) 240-7090 | |
| Not Available |
| Full Name | Dr Raymond Justin Myles Jr |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 10 Years |
| Location | 609a Warrior Road, Fort Riley, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073970547 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 571 (Wyoming) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clarity Clinic Llc | 7517284755 | 65 |
News Archive
Cell Therapeutics, Inc. today reported exploratory analyses of the data at study completion from the Company's pivotal PIX301 trial of Pixuvri, the first randomized controlled trial in patients with relapsed or refractory, aggressive non-Hodgkin's lymphoma.
In a Journal of the American Geriatrics Society study of adults aged 65 and older who were functionally independent, individuals with cardiovascular disease were more likely to experience rapid functional decline than those without.
Sangamo BioSciences, Inc. announced that data from its Phase 1 clinical programs to develop SB-728-T, a novel therapeutic approach designed to generate a "functional cure" for HIV/AIDS, were presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
InSite Vision Incorporated, a company developing ophthalmic products for unmet eye care needs, today announced plans to advance new development candidate ISV-303, a topical anti-inflammatory product intended to reduce the pain and swelling associated with ocular surgery.
› Verified 8 days ago
| Entity Name | Clarity Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063803856 PECOS PAC ID: 7517284755 Enrollment ID: O20150326001469 |
News Archive
Cell Therapeutics, Inc. today reported exploratory analyses of the data at study completion from the Company's pivotal PIX301 trial of Pixuvri, the first randomized controlled trial in patients with relapsed or refractory, aggressive non-Hodgkin's lymphoma.
In a Journal of the American Geriatrics Society study of adults aged 65 and older who were functionally independent, individuals with cardiovascular disease were more likely to experience rapid functional decline than those without.
Sangamo BioSciences, Inc. announced that data from its Phase 1 clinical programs to develop SB-728-T, a novel therapeutic approach designed to generate a "functional cure" for HIV/AIDS, were presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
InSite Vision Incorporated, a company developing ophthalmic products for unmet eye care needs, today announced plans to advance new development candidate ISV-303, a topical anti-inflammatory product intended to reduce the pain and swelling associated with ocular surgery.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Raymond Justin Myles Jr, PSYD 609 A Warrior Road, Fort Riley, KS 66442 Ph: (785) 240-7090 | Dr Raymond Justin Myles Jr, PSYD 609a Warrior Road, Fort Riley, KS 66442 Ph: (785) 240-7090 |
News Archive
Cell Therapeutics, Inc. today reported exploratory analyses of the data at study completion from the Company's pivotal PIX301 trial of Pixuvri, the first randomized controlled trial in patients with relapsed or refractory, aggressive non-Hodgkin's lymphoma.
In a Journal of the American Geriatrics Society study of adults aged 65 and older who were functionally independent, individuals with cardiovascular disease were more likely to experience rapid functional decline than those without.
Sangamo BioSciences, Inc. announced that data from its Phase 1 clinical programs to develop SB-728-T, a novel therapeutic approach designed to generate a "functional cure" for HIV/AIDS, were presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
InSite Vision Incorporated, a company developing ophthalmic products for unmet eye care needs, today announced plans to advance new development candidate ISV-303, a topical anti-inflammatory product intended to reduce the pain and swelling associated with ocular surgery.
› Verified 8 days ago
Steven Robles, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 650 Huebner Rd, Fort Riley, KS 66442 Phone: 785-239-3627 | |
Mr. Dennis J. Blair, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: Irwin Army Community Hospital, 600 Caisson Hill Road, Fort Riley, KS 66442 Phone: 785-239-7155 Fax: 785-239-7364 | |
Stephen Sheets, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 650 Huebner Rd, Fort Riley, KS 66442 Phone: 785-239-7667 | |
Dr. Lauren C Lachica-muschett, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 650 Huebner Rd, Fort Riley, KS 66442 Phone: 785-239-7151 | |
Katherine Renee Robles, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 650 Huebner Rd, Fort Riley, KS 66442 Phone: 852-397-1517 | |
Charles F. Bass, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 600 Caisson Hill Road, Fort Riley, KS 66442 Phone: 785-239-7155 Fax: 785-239-7364 |